Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Food and Drug Administration (FDA)
Biotech
Makary FDA reforms ‘continue to move forward’ despite turmoil
Makary's namesake program, the controversial Commissioner’s National Priority Voucher, remains unchanged in name and direction, Fierce has learned.
Darren Incorvaia
May 26, 2026 10:27am
CBER chief Prasad steps aside, deputy takes the reins
May 1, 2026 9:58am
FDA unveils plan for real-time review of clinical trial data
Apr 28, 2026 1:52pm
FDA celebrates animal testing shift as experts eye road ahead
Apr 19, 2026 6:00pm
AACR: Pazdur bemoans state of FDA, warns of political influence
Apr 18, 2026 4:00am
Can’t plausible mechanism principles apply to uniQure?
Apr 15, 2026 4:00am